Avenue Therapeutics, Inc. (ATXI) SEC filings
ATXI SEC filings moved a median of -0.98% by the close. ATXI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ATXI overview →
56 measured ATXI SEC filing events.
Where these ATXI SEC filings landedvs 55 measured ATXI SEC filing reactions
| Middle 50% of ATXI SEC filing reactions | -3.63% to +2.02% |
|---|---|
| Median reaction (to close) | -0.98% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 ATXI SEC filing events with a measured close landed between -3.63% and +2.02%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -47.69% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -3.67% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 8-K AVENUE THERAPEUTICS, For: Feb 18 | SEC filing · Form 8-K | +28.01% | +42.06% | |
| Form 8-K AVENUE THERAPEUTICS, For: Dec 30 | SEC filing · Form 8-K | -3.50% | -4.87% | |
| Form EFFECT AVENUE THERAPEUTICS, | SEC filing · Form EFFECT | +0.00% | +0.08% | |
| Form POS AM AVENUE THERAPEUTICS, | SEC filing · Form POS | +0.00% | +3.73% | |
| Form RW AVENUE THERAPEUTICS, | SEC filing · Form RW | +0.00% | +3.73% | |
| Form DEF 14A AVENUE THERAPEUTICS, For: Dec 30 | SEC filing · Form DEF | +0.00% | -12.64% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 14 | SEC filing · Form 8-K | +14.28% | +2.23% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 05 | SEC filing · Form 8-K | +0.00% | +0.13% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +20.57% | +61.47% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K AVENUE THERAPEUTICS, For: Apr 24 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +1.20% | -3.33% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 17 | SEC filing · Form 8-K | -7.10% | -23.50% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 07 | SEC filing · Form 8-K | +0.00% | +5.05% | |
| Form S-3 AVENUE THERAPEUTICS, | SEC filing · Form S-3 | +0.00% | -2.67% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 26 | SEC filing · Form 8-K | -2.72% | +5.43% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -3.23% | +3.76% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 14 | SEC filing · Form 8-K | -3.23% | +3.76% | |
| Form 8-K AVENUE THERAPEUTICS, For: Sep 23 | SEC filing · Form 8-K | -2.72% | -3.11% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | — | +1.63% | |
| Form 8-K AVENUE THERAPEUTICS, For: Aug 09 | SEC filing · Form 8-K | — | +1.63% | |
| Form S-8 AVENUE THERAPEUTICS, | SEC filing · Form S-8 | — | +2.05% | |
| Form 8-K AVENUE THERAPEUTICS, For: Jun 24 | SEC filing · Form 8-K | -1.61% | -0.83% | |
| Form 8-K AVENUE THERAPEUTICS, For: May 21 | SEC filing · Form 8-K | -0.21% | -3.98% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +3.54% | -1.09% | |
| Form 8-K AVENUE THERAPEUTICS, For: May 15 | SEC filing · Form 8-K | -0.27% | -1.62% | |
| Form 8-K AVENUE THERAPEUTICS, For: May 10 | SEC filing · Form 8-K | -0.26% | +2.33% | |
| Form EFFECT AVENUE THERAPEUTICS, | SEC filing · Form EFFECT | -0.26% | +2.33% | |
| Form DEF 14A AVENUE THERAPEUTICS, For: Jun 22 | SEC filing · Form DEF | +0.21% | -3.63% | |
| Form DEFA14A AVENUE THERAPEUTICS, | SEC filing · Form DEFA14A | +0.21% | -3.63% | |
| Form S-3 AVENUE THERAPEUTICS, | SEC filing · Form S-3 | +0.21% | -3.63% | |
| Form 8-K AVENUE THERAPEUTICS, For: May 01 | SEC filing · Form 8-K | +0.00% | -0.63% | |
| Form 8-K AVENUE THERAPEUTICS, For: Apr 25 | SEC filing · Form 8-K | -0.99% | -10.95% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 26 | SEC filing · Form 8-K | -1.82% | -2.53% | |
| Form 10-K AVENUE THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -3.85% | -3.61% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 18 | SEC filing · Form 8-K | -3.85% | -3.61% | |
| Form DEF 14C AVENUE THERAPEUTICS, For: Mar 18 | SEC filing · Form DEF | -3.85% | -3.61% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 11 | SEC filing · Form 8-K | +1.73% | +0.77% | |
| Form 8-K AVENUE THERAPEUTICS, For: Mar 06 | SEC filing · Form 8-K | -8.57% | -9.24% | |
| Form PRE 14C AVENUE THERAPEUTICS, For: Mar 08 | SEC filing · Form PRE | -8.57% | -9.24% | |
| Form 8-K AVENUE THERAPEUTICS, For: Feb 20 | SEC filing · Form 8-K | +0.72% | +5.91% | |
| Form EFFECT AVENUE THERAPEUTICS, | SEC filing · Form EFFECT | -1.77% | -4.63% | |
| Form DEF 14C AVENUE THERAPEUTICS, For: Jan 29 | SEC filing · Form DEF | -2.27% | +1.00% | |
| Form S-3 AVENUE THERAPEUTICS, | SEC filing · Form S-3 | +0.00% | -0.98% | |
| Form PRE 14C AVENUE THERAPEUTICS, For: Jan 17 | SEC filing · Form PRE | +0.99% | +2.84% | |
| Form 8-K AVENUE THERAPEUTICS, For: Jan 09 | SEC filing · Form 8-K | +3.93% | -2.25% | |
| Form 8-K AVENUE THERAPEUTICS, For: Jan 05 | SEC filing · Form 8-K | -0.97% | +2.00% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 20 | SEC filing · Form 8-K | — | +0.00% | |
| Form 10-Q AVENUE THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +0.07% | -2.88% | |
| Form 8-K AVENUE THERAPEUTICS, For: Nov 13 | SEC filing · Form 8-K | +0.07% | -2.88% | |
| Form 8-K AVENUE THERAPEUTICS, For: Oct 31 | SEC filing · Form 8-K | +2.00% | +0.08% | |
| Form EFFECT AVENUE THERAPEUTICS, | SEC filing · Form EFFECT | -3.25% | -10.99% | |
| Form S-1/A AVENUE THERAPEUTICS, | SEC filing · Form S-1 | +0.00% | -15.36% |
Keep exploring
More ATXI: earnings → · analyst actions → · ATXI overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Protagenic Therapeutics, Inc. (PTIX) | 121 | 0.00% | 39% |
| Xenetic Biosciences, Inc. (XBIO) | 121 | 0.00% | 38% |
| CARL ZEISS MEDI UNSP/ADR (CZMWY) | 120 | -0.21% | 21% |
| HEMP NATURALS INC (HPMM) | 120 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.